LPS alters placental inflammatory and endocrine mediators and inhibits fetal neurite growth in affected offspring during late gestation

Placenta

Volumn 35, Issue 8, 2014, Pages 533-538

  Straley, M E ^a,b   Togher, K L ^a,b   Nolan, A M ^b   Kenny, L C ^a   O'Keeffe, G W ^a,b  

^a Irish Centre for Fetal and Neonatal Translational Research   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

LPS; Maternal infection; Neuron; Placenta; Pregnancy

Indexed keywords

LIPOPOLYSACCHARIDE; SODIUM CHLORIDE; 11BETA HYDROXYSTEROID DEHYDROGENASE 2; CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIRTH; CONTROLLED STUDY; CROWN RUMP LENGTH; EMBRYO; ENDOCRINE FUNCTION; ENVIRONMENTAL EXPOSURE; FEMALE; FETUS WEIGHT; GESTATIONAL AGE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INFECTION; MATERNAL INFECTION; NERVE FIBER GROWTH; NONHUMAN; PLACENTA; PLACENTA WEIGHT; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; PROGENY; RAT; ANIMAL; CELL CULTURE; DISEASE MODEL; EMBRYOLOGY; FETUS; METABOLISM; NERVOUS SYSTEM; NEURITE; PATHOLOGY; PHYSIOLOGY; PREGNANCY COMPLICATION; SPRAGUE DAWLEY RAT;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2; ANIMALS; CELLS, CULTURED; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; FETUS; HUMANS; LIPOPOLYSACCHARIDES; NERVOUS SYSTEM; NEURITES; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RATS, SPRAGUE-DAWLEY;

EID: 84905375859     PISSN: 01434004     EISSN: 15323102     Source Type: Journal    
DOI: 10.1016/j.placenta.2014.06.001     Document Type: Article

References (40)

1. W. Schlotz, and D.I. Phillips Fetal origins of mental health: evidence and mechanisms Brain Behav Immun 23 7 2009 905 916
2. A.S. Brown, M.D. Begg, S. Gravenstein, C.A. Schaefer, R.J. Wyatt, and M. Bresnahan et al. Serologic evidence of prenatal influenza in the etiology of schizophrenia Arch Gen Psychiatry 61 8 2004 774 780
3. A.S. Brown, C.A. Schaefer, C.P. Quesenberry Jr., L. Liu, V.P. Babulas, and E.S. Susser Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring Am J Psychiatry 162 4 2005 767 773
4. O. Zerbo, Y. Qian, C. Yoshida, J.K. Grether, J. Van de Water, and L.A. Croen Maternal infection during pregnancy and autism spectrum disorders J Autism Dev Disord 2013
5. O. Zerbo, A.M. Iosif, C. Walker, S. Ozonoff, R.L. Hansen, and I. Hertz-Picciotto Is maternal influenza or fever during pregnancy associated with autism or developmental delays? results from the CHARGE (CHildhood Autism Risks from Genetics and Environment) study J Autism Dev Disord 43 1 2013 25 33
6. J.G. Shatrov, S.C. Birch, L.T. Lam, J.A. Quinlivan, S. McIntyre, and G.L. Mendz Chorioamnionitis and cerebral palsy: a meta-analysis Obstet Gynecol 116 2 Pt 1 2010 387 392
7. S.E. Canetta, and A.S. Brown Prenatal infection, maternal immune activation, and risk for schizophrenia Transl Neurosci 3 4 2012 320 327
8. P. Boksa Effects of prenatal infection on brain development and behavior: a review of findings from animal models Brain Behav Immun 24 6 2010 881 897
9. B. Huppertz The anatomy of the normal placenta J Clin Pathol 61 12 2008 1296 1302
10. The placenta and neurodisability 2006 Mac Keith Press
11. G.W. O'Keeffe, and L.C. Kenny Predicting infant neurodevelopmental outcomes using the placenta? Trends Mol Med 20 2014 303 305
12. A.K. von Beckerath, M. Kollmann, C. Rotky-Fast, E. Karpf, U. Lang, and P. Klaritsch Perinatal complications and long-term neurodevelopmental outcome of infants with intrauterine growth restriction Am J Obstet Gynecol 208 2 2013 130 e1-6
13. H.O. Atladottir, P. Thorsen, L. Ostergaard, D.E. Schendel, S. Lemcke, and M. Abdallah et al. Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders J Autism Dev Disord 40 12 2010 1423 1430
14. H.J. Sorensen, E.L. Mortensen, J.M. Reinisch, and S.A. Mednick Association between prenatal exposure to bacterial infection and risk of schizophrenia Schizophr Bull 35 3 2009 631 637
15. P.H. Patterson Maternal infection and immune involvement in autism Trends Mol Med 17 7 2011 389 394
16. L. Harvey, and P. Boksa Prenatal and postnatal animal models of immune activation: relevance to a range of neurodevelopmental disorders Dev Neurobiol 72 10 2012 1335 1348
17. N.O. Glebova, and D.D. Ginty Growth and survival signals controlling sympathetic nervous system development Annu Rev Neurosci 28 2005 191 222
18. A.M. Nolan, Y.M. Nolan, and G.W. O'Keeffe IL-1beta inhibits axonal growth of developing sympathetic neurons Mol Cell Neurosci 48 2 2011 142 150
19. E.C. Cottrell, J.R. Seckl, M.C. Holmes, and C.S. Wyrwoll Foetal and placental 11beta-HSD2: a hub for developmental programming Acta Physiol 210 2 2013 288 295
20. K.L. Togher, M.M. O'Keeffe, A.S. Khashan, H. Gutierrez, L.C. Kenny, and G.W. O'Keeffe Epigenetic regulation of the placental HSD11B2 barrier and its role as a critical regulator of fetal development Epigenetics 9 6 2014 0 1
21. M.C. Holmes, C.T. Abrahamsen, K.L. French, J.M. Paterson, J.J. Mullins, and J.R. Seckl The mother or the fetus? 11beta-hydroxysteroid dehydrogenase type 2 null mice provide evidence for direct fetal programming of behavior by endogenous glucocorticoids J Neurosci 26 14 2006 3840 3844
22. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method Methods 25 4 2001 402 408
23. H. Gutierrez, and A.M. Davies A fast and accurate procedure for deriving the Sholl profile in quantitative studies of neuronal morphology J Neurosci Methods 163 1 2007 24 30
24. M. Shams, M.D. Kilby, D.A. Somerset, A.J. Howie, A. Gupta, and P.J. Wood et al. 11Beta-hydroxysteroid dehydrogenase type 2 in human pregnancy and reduced expression in intrauterine growth restriction Hum Reprod 13 4 1998 799 804
25. R. Benediktsson, R. Lindsay, J. Noble, J. Seckl, and C. Edwards Glucocorticoid exposure in utero: new model for adult hypertension Lancet 341 8841 1993 339 341
26. G.J. Pepe, J.S. Babischkin, M.G. Burch, M.G. Leavitt, and E.D. Albrecht Developmental increase in expression of the messenger ribonucleic acid and protein levels of 11beta-hydroxysteroid dehydrogenase types 1 and 2 in the baboon placenta Endocrinology 137 12 1996 5678 5684
27. R.W. Brown, R. Diaz, A.C. Robson, Y.V. Kotelevtsev, J.J. Mullins, and M.H. Kaufman et al. The ontogeny of 11 beta-hydroxysteroid dehydrogenase type 2 and mineralocorticoid receptor gene expression reveal intricate control of glucocorticoid action in development Endocrinology 137 2 1996 794 797
28. P.J. Burton, and B.J. Waddell 11β-Hydroxysteroid dehydrogenase in the rat placenta: developmental changes and the effects of altered glucocorticoid exposure J Endocrinol 143 3 1994 505 513
29. F. Staud, K. Mazancova, I. Miksik, P. Pavek, Z. Fendrich, and J. Pacha Corticosterone transfer and metabolism in the dually perfused rat placenta: effect of 11beta-hydroxysteroid dehydrogenase type 2 Placenta 27 2-3 2006 171 180
30. B.J. Waddell, R. Benediktsson, R.W. Brown, and J.R. Seckl Tissue-specific messenger ribonucleic acid expression of 11beta-hydroxysteroid dehydrogenase types 1 and 2 and the glucocorticoid receptor within rat placenta suggests exquisite local control of glucocorticoid action Endocrinology 139 4 1998 1517 1523
31. P.J. Burton, R.E. Smith, Z.S. Krozowski, and B.J. Waddell Zonal distribution of 11 beta-hydroxysteroid dehydrogenase types 1 and 2 messenger ribonucleic acid expression in the rat placenta and decidua during late pregnancy Biol Reprod 55 5 1996 1023 1028
32. E.C. Cottrell, M.C. Holmes, D.E. Livingstone, C.J. Kenyon, and J.R. Seckl Reconciling the nutritional and glucocorticoid hypotheses of fetal programming FASEB J 26 5 2012 1866 1874
33. J.S. Cuffe, L. O'Sullivan, D.G. Simmons, S.T. Anderson, and K.M. Moritz Maternal corticosterone exposure in the mouse has sex-specific effects on placental growth and mRNA expression Endocrinology 153 11 2012 5500 5511
34. C.D. Heiniger, M.K. Rochat, F.J. Frey, and B.M. Frey TNF-alpha enhances intracellular glucocorticoid availability FEBS Lett 507 3 2001 351 356
35. I. Kossintseva, S. Wong, E. Johnstone, L. Guilbert, D.M. Olson, and B.F. Mitchell Proinflammatory cytokines inhibit human placental 11beta-hydroxysteroid dehydrogenase type 2 activity through Ca2+ and cAMP pathways Am J physiol Endocrinol metab 290 2 2006 E282 E288
36. H. Chisaka, J.F. Johnstone, M. Premyslova, Z. Manduch, and J.R. Challis Effect of pro-inflammatory cytokines on expression and activity of 11beta-hydroxysteroid dehydrogenase type 2 in cultured human term placental trophoblast and human choriocarcinoma JEG-3 cells J Soc Gynecol Investig 12 5 2005 303 309
37. C.S. Wyrwoll, J.R. Seckl, and M.C. Holmes Altered placental function of 11beta-hydroxysteroid dehydrogenase 2 knockout mice Endocrinology 150 3 2009 1287 1293
38. S. Girard, H. Sebire, M.E. Brochu, S. Briota, P. Sarret, and G. Sebire Postnatal administration of IL-1Ra exerts neuroprotective effects following perinatal inflammation and/or hypoxic-ischemic injuries Brain Behav Immun 26 8 2012 1331 1339
39. B. Clancy, B.L. Finlay, R.B. Darlington, and K.J. Anand Extrapolating brain development from experimental species to humans Neurotoxicology 28 5 2007 931 937
40. Y.Q. Koh, H.W. Chan, M.D. Nitert, K. Vaswani, M.D. Mitchell, and G.E. Rice Differential response to lipopolysaccharide by JEG-3 and BeWo human choriocarcinoma cell lines Eur J Obstet Gynecol Reprod Biol 175 2014 129 133